| 英文名称 | 中文名称 | CAS | MF |
|
(+)-N-[(S)-α-(Chloromethyl)benzyl]acetamide
|
|
|
|
|
N-[(S)-1-(4-Chlorophenyl)-2-[(3-methoxypropyl)pentylamino]-2-oxoethyl]acetamide
|
|
|
C19H29ClN2O3
|
|
(+)-N-[(S)-2-Chloro-1-methylethyl]-N-methylformamide
|
|
|
C5H10ClNO
|
|
(-)-N-[(S)-3-Chloro-1-methyl-2-oxopropyl]phthalimide
|
|
|
C12H10ClNO3
|
|
N-[(S)-1-(4-Chlorophenyl)-2-[(3-methoxypropyl)pentylamino]-2-oxoethyl]-4-hydroxybenzeneacetamide
|
|
|
C25H33ClN2O4
|
|
N-{4-[(1S)-2-chloro-1-hydroxyethyl]phenyl}-N-methylmethanesulfonamide
|
|
|
C10H14ClNO3S
|
|
N-{4-[(1S)-2-chloro-1-hydroxyethyl]phenyl}-N-ethylmethanesulfonamide
|
|
|
C11H16ClNO3S
|
|
N-{4-[(1S)-2-chloro-1-hydroxyethyl]phenyl}methanesulfonamide
|
|
|
C9H12ClNO3S
|
|
N-(2-{4-[(1S)-2-chloro-1-hydroxyethyl]phenyl}ethyl)methanesulfonamide
|
|
|
C11H16ClNO3S
|
|
N-[[(1S)-11-Bromo-1,2,7,8,13,13bβ-hexahydro-10-hydroxy[1,6,2]oxathiazepino[2',3':1,2]pyrido[3,4-b]indol]-1α-yl]-2-hydroxyacetamide
|
|
96426-93-6
|
C16H18BrN3O4S
|
|
N-[(1S)-2β-Bromocycloheptan-1α-yl]acetamide
|
|
|
|
|
(-)-N-[(S)-2-Bromohexanoyl]glycine
|
|
|
C8H14BrNO3
|
|
(-)-N-[(S)-2-Bromopropionyl]glycine
|
|
|
C5H8BrNO3
|
|
(+)-N-[(S)-α-(Bromomethyl)benzyl]acetamide
|
|
|
|
|
(-)-N-[(S)-3-Bromo-1-methyl-2-oxopropyl]phthalimide
|
|
|
C12H10BrNO3
|
|
Nα-[(2S)-3-(5-Bromo-1H-indol-3-yl)-2-aminopropionyl]-L-tryptophan
|
|
|
|
|
(-)-N-[(S)-α-(Bromoacetyl)-p-methoxyphenethyl]phthalimide
|
|
|
|
|
(-)-N-[(S)-2-Bromobutyryl]glycine
|
|
|
C6H10BrNO3
|
|
(-)-N-[(S)-2-Bromo-4-methylvaleryl]glycine
|
|
|
C8H14BrNO3
|
|
N-[(1S)-2β-Bromocyclopentan-1α-yl]acetamide
|
|
|
|
|
(-)-N-[(S)-2-Bromo-3-methylbutyryl]glycine
|
|
|
C7H12BrNO3
|
|
N-[(8α,9S)-cinchonan-9-yl]-3,5-bis(trifluoroMethyl)-BenzenesulfonaMide
|
普瑞巴林杂质B
|
1253690-78-6
|
C27H25F6N3O2S
|
|
N-(8α,9S)-cinchonan-9-yl-N'-[(2R)-2-pyrrolidinylMethyl]-Thiourea
|
N-[(8Α,9S)-奎宁-9-基]-N'-[(2R)-2-吡咯烷基甲基]硫脲
|
1222966-43-9
|
C25H33N5S
|
|
N-(8α,9S)-cinchonan-9-yl-N'-[(2S)-2-pyrrolidinylMethyl]-Thiourea
|
N-(8Α,9S)-奎宁-9-基]-N'-[(2S)-2-吡咯烷基甲基]硫脲
|
1222966-34-8
|
C25H33N5S
|
|
NSC632839hydrochloride
|
NSC632839hydrochloride
|
157654-67-6
|
C21H21NO.ClH
|
|
NSC 23766 (hydrochloride)
|
NSC23766
|
1177865-17-6
|
C24H35N7
|
|
NR-LU-10 antibody
|
|
|
|
|
(+)-N-[[(R)-N-Benzyloxycarbonyl-3-cyano-D-alanyl]oxy]succinimide
|
|
|
C16H15N3O6
|
|
N-((R)-1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoroMethyl)phenyl)propanaMide
|
西那卡塞中间体
|
1005450-55-4
|
C22H20F3NO
|
|
N-[(R)-1-(1-Naphtyl)ethyl]carbamic acid (E)-3-cyclohexylallyl ester
|
|
|
C22H27NO2
|
|
(-)-N-[(R)-2-(2-Naphtyl)propionyl]-4-morpholinecarbothioamide
|
|
|
C18H20N2O2S
|
|
(+)-N-[(R)-1-(1-Naphtyl)ethyl]formamide
|
|
|
C13H13NO
|
|
N-[(R)-1-(1-NAPHTHYL)ETHYL]PHTHALAMIC ACID
|
|
|
C20H17NO3
|
|
NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa51-67
|
|
|
|
|
NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa14-30
|
|
|
|
|
NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa51-67 Control Peptide (KLH)
|
|
|
|
|
NSCL1 (HEN1, Helix-loop-helix Transcription Factor), aa51-67 Control Peptide
|
|
|
|
|
N-[(S)-Butan-2-yl]adenosine
|
|
|
C14H21N5O4
|
|
N-[[(2S)-1-Butyl-2-pyrrolidinyl]methyl]-2-methoxy-5-sulfamoylbenzamide
|
|
|
C17H27N3O4S
|
|
N-[3-[(S)-2-Butyrylamino-3-(4-hydroxy-3,5-diiodophenyl)propanoylamino]propyl]-N'-[3-[(S)-2-amino-4-guanidinobutyrylamino]propyl]butane-1,4-diamine
|
|
|
C28H49I2N9O4
|
|
NSCL protein
|
|
|
|
|
N-[[(2S)-1-Decylpyrrolidin-2α-yl]methyl]-2-methoxy-5-sulfamoylbenzamide
|
|
|
|
|
N-(2-(S-coenzyme A)acetyl)spermidine
|
|
83889-68-3
|
C30H55N10O17P3S
|
|
NSC25872#NSC41835
|
磺胺吡嗪
|
116-44-9
|
C10H10N4O2S
|
|
N-[[[(5S)-5α-[[6-Deoxy-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6β,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen]-2-yl]carbonyl]-D-alanine methyl ester
|
|
|
|
|
N-[[[(5S)-5α-[[6-Deoxy-β-D-galactopyranosyl]oxy]-5,6,8,13-tetrahydro-1,6β,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo[a]naphthacen]-2-yl]carbonyl]-D-alanine
|
|
|
|
|
Nα-[(2R)-2-(Morpholinocarbonylmethyl)-3-(1-naphthalenyl)propionyl]-L-His-[(2R,3S)-3-amino*-2-hydroxy-5-methylhexanoic acid]isopropyl ester
|
|
|
|
|
Nα-[(2R)-3-(Morpholinocarbonyl)-2-(1-naphtylmethyl)propionyl]-L-histidine methyl ester
|
|
|
|
|
NRN1 (full length)
|
|
|
|
|
NSE
|
NSE
|
|
|
|
NQ Y15
|
|
|
|
|
N,S-DIACETYL-L-CYSTEINE METHYL ESTER
|
(R)-甲基2-乙酰胺基-3-(乙酰基硫基)丙酸酯
|
19547-88-7
|
C8H13NO4S
|
|
N-[(1S)-4-(diaminomethylideneamino)-1-[(9-ethylcarbazol-3-yl)carbamoyl ]butyl]benzamide
|
|
82576-33-8
|
C27H30N6O2
|
|
N,S-DIACETYLCYSTEAMINE
|
N,S-二乙酰半胱胺
|
1420-88-8
|
C6H11NO2S
|
|
N,S-DIACETYLCYSTEINE
|
|
|
C7H11NO4S
|
|
3-N'-[(S)-3,6-Diaminohexanoyl]amphotericin B methyl ester
|
|
|
|
|
(+)-N-[(S)-4-Diazo-1-methyl-3-oxobutyl]phthalimide
|
|
|
C13H11N3O3
|
|
(+)-N-[(S)-4-Diazo-2-methyl-3-oxobutyl]phthalimide
|
|
|
C13H11N3O3
|
|
3-N'-[(S)-2,4-Diaminobutyryl]amphotericin B methyl ester
|
|
|
|
|
N-[(S)-1-(Diazoacetyl)-3-methylbutyl]-4-methylbenzenesulfonamide
|
|
|
C14H19N3O3S
|
|
N-[3-[(S)-2,6-Diaminohexanoylamino]propyl]-N'-[3-[(S)-2-butyrylamino-3-(4-hydroxy-3,5-diiodophenyl)propanoylamino]propyl]butane-1,4-diamine
|
|
|
C29H51I2N7O4
|
|
N-[3-[(S)-2,6-Diaminohexanoylamino]propyl]-N'-[3-[(S)-2-butyrylamino-3-[4-hydroxy-3,5-di[(125I)iodo]phenyl]propanoylamino]propyl]butane-1,4-diamine
|
|
|
|
|
(+)-N-[(S)-5-Diazo-3-methyl-4-oxopentyl]phthalimide
|
|
|
C14H13N3O3
|
|
(-)-N-[(S)-6-Diazo-3-methyl-5-oxohexyl]phthalimide
|
|
|
C15H15N3O3
|
|
(-)-N-[(S)-1-(Diazoacetyl)butyl]phthalimide
|
|
|
C14H13N3O3
|
|
(-)-N-[(S)-α-Diazoacetyl-p-methoxyphenethyl]phthalimide
|
|
|
|
|
(-)-N-[(S)-1,2-Dicyclohexylethyl]maleimide
|
|
|
C18H27NO2
|
|
N-[(S)-1,2-Dicarboxyethyl]-D-glutamic acid
|
|
90245-73-1
|
|
|
(-)-N-[(S)-1,2-Di(cyclohexyl)ethyl]phthalimide
|
|
|
C22H29NO2
|
|
N-[2-[[(2S)-2α,6-Dicarboxy-1,2,3,4-tetrahydropyridin]-4-ylidene]ethylidene]glycine
|
|
135545-99-2
|
C11H12N2O6
|
|
(-)-N-[(S)-1,2-Dicyclohexylethyl]-2-methylenesuccinimide
|
|
|
C19H29NO2
|
|
N-[(S)-1-(2,4-DICHLOROPHENYL)ETHYL]-2-CYANO-3,3-DIMETHYLBUTANAMIDE
|
|
|
C15H18Cl2N2O
|
|
N,S-DI(2,4-DNP)-L-CYSTEINE
|
|
1655-62-5
|
C15H11N5O10S
|
|
(-)-N-[(S)-α-Diethoxymethyl-p-methoxyphenethyl]phthalimide
|
|
|
|
|
N-[(1S)-2,3-dihydro-1H-inden-1-yl]-1H-pyrrolo[2,3-d]pyriMidin-4-aMine
|
(S)-N-(2,3-二氢-1H-茚-1-基)-7H-吡咯并[2,3-D]嘧啶-4-胺
|
905580-86-1
|
C15H14N4
|
|
N-[[(S)-2,3-Dihydro-1H-inden]-1β-yl]adenosine
|
|
|
|
|
N-[[(S)-2,3-Dihydro-5-methoxy-1H-inden]-1β-yl]adenosine
|
|
|
|
|
N-[(1S)-1-[[[(2,3-Dihydro-1H-inden)-2-yl][[[2-(trifluoroacetyl)propan-2-yl]carbamoyl]methyl]amino]carbonyl]-2-methylpropyl]-N'-[(4-chlorophenyl)sulfonyl]terephthalamide
|
|
|
C35H36ClF3N4O7S
|
|
(+)-N-[(S)-3,β-Dihydroxyphenethyl]-N-methylacetamide
|
|
|
|
|
N-[[(S)-2,3-Dihydro-5-butoxy-1H-inden]-1β-yl]adenosine
|
|
|
|
|
(+)-N-[(S)-β,3-Dihydroxy-4-nitrophenethyl]-N-methylacetamide
|
|
|
|
|
N-[(1S)-1-[[[(2,3-Dihydro-1H-inden)-2-yl][[(2-oxo-3,3,3-trifluoropropyl)carbamoyl]methyl]amino]carbonyl]-2-methylpropyl]-N'-[(4-chlorophenyl)sulfonyl]terephthalamide
|
|
|
C33H32ClF3N4O7S
|
|
NSD2 (human recombinant)
|
|
|
|
|
N1-[(1S)-2,2-Dimethyl-1-[[[(1R)-1-phenylethyl]amino]carbonyl]propyl]-N4-hydroxy-2-[3-(2-methyl[1,1'-biphenyl]-4-yl)propyl]-butanediamine
|
UK 356618
|
230961-08-7
|
C34H43N3O4
|
|
N-[(20S)-20-(Dimethylamino)-16β-hydroxy-4,4,14-trimethyl-11-oxo-9,19-cyclo-5α-pregnan-3β-yl]benzamide
|
|
15524-62-6
|
C33H48N2O3
|
|
N-[(20S)-4,14-Dimethyl-20-(dimethylamino)-16β-hydroxy-4β-(hydroxymethyl)-9β,19-cyclo-5α-pregnan-3β-yl]benzamide
|
|
17934-60-0
|
C33H50N2O3
|
|
N-[(5S,6β,7β,10α)-2,10-Dimethyl-7-isopropylspiro[4.5]dec-1-en-6-yl]formamide
|
|
|
|
|
(-)-N-[(S)-1-(5,8-Dimethyl-2-naphtyl)ethyl]benzamide
|
|
|
C21H21NO
|
|
N-[(2S)-2,4-Dimethyl-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentanoyl]glycinamide
|
|
|
C14H24N4O4
|
|
N-[[S,(+)]-2-(3,3-Dimethylpiperidino)-1-methylethyl]-N-(2-pyridyl)propionamide
|
|
24608-95-5
|
C18H29N3O
|
|
N-[(2S)-2,4-Dimethyl-2-[[[(2S)-pyrrolidin-2-yl]carbonyl]amino]pentanoyl]glycinamide
|
|
|
C14H26N4O3
|
|
(-)-N-[(S)-1-(3,4-Dimethoxybenzoyl)ethyl]phthalimide
|
|
|
C19H17NO5
|
|
(+)-N-[(S)-3,4-Dimethoxy-α-methylphenethyl]-p-toluenesulfonamide
|
|
|
|
|
N-[(20S)-20-(Dimethylamino)-16α-hydroxy-4α-(hydroxymethyl)-4,14-dimethyl-11-oxo-9β,19-cyclo-5α-pregnan-3β-yl]-2-methylpropanamide
|
|
4947-53-9
|
C30H50N2O4
|
|
(+)-N-[(S)-1,2-Dimethylpropyl]-4-nitrobenzamide
|
|
|
C12H16N2O3
|
|
N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-2,2-DIMETHYLPROPANAMIDE
|
|
|
C18H23N3O3S
|
|
N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-2,2-DIPHENYLACETAMIDE
|
|
|
C27H25N3O3S
|
|
N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-4-(ETHYLTHIO)BENZAMIDE
|
|
|
C22H23N3O3S2
|
|
N-[S-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)METHYL]-4-THIOPHENYL]-4-NITROBENZAMIDE
|
|
|
C20H18N4O5S
|
|
N4-{[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl}pyrimidine-4,5-diamine
|
|
|
C10H16N4O2
|